These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10767508)

  • 41. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children.
    Abrams EJ; Wiener J; Carter R; Kuhn L; Palumbo P; Nesheim S; Lee F; Vink P; Bulterys M;
    AIDS; 2003 Apr; 17(6):867-77. PubMed ID: 12660534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vasculoplacental complications in pregnant women with HIV infection: a case-control study.
    Canlorbe G; Matheron S; Mandelbrot L; Oudet B; Luton D; Azria E
    Am J Obstet Gynecol; 2015 Aug; 213(2):241.e1-9. PubMed ID: 25797234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
    Palacios R; Senise J; Vaz M; Diaz R; Castelo A
    HIV Med; 2009 Mar; 10(3):157-62. PubMed ID: 19245537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV-1 infection and pregnancy in young women in Brazil: socioeconomic and drug resistance profiles in a cross-sectional study.
    Lima YA; Reis MN; Cardoso LP; Stefani MM
    BMJ Open; 2016 Jul; 6(7):e010837. PubMed ID: 27381205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine.
    Ekpini RA; Nkengasong JN; Sibailly T; Maurice C; Adjé C; Monga BB; Roels TH; Greenberg AE; Wiktor SZ
    AIDS; 2002 Mar; 16(4):625-30. PubMed ID: 11873007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy.
    Kaufmann GR; Bloch M; Finlayson R; Zaunders J; Smith D; Cooper DA
    AIDS; 2002 Feb; 16(3):359-67. PubMed ID: 11834947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count.
    Rizzardi GP; Tambussi G; Bart PA; Chapuis AG; Lazzarin A; Pantaleo G
    AIDS; 2000 Oct; 14(15):2257-63. PubMed ID: 11089613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of pregnancy on maternal AIDS.
    Kumar RM; Uduman SA; Khurrana AK
    J Reprod Med; 1997 Jul; 42(7):429-34. PubMed ID: 9252934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nelfinavir and nevirapine side effects during pregnancy.
    Timmermans S; Tempelman C; Godfried MH; Nellen J; Dieleman J; Sprenger H; Schneider ME; de Wolf F; Boer K; van der Ende ME;
    AIDS; 2005 May; 19(8):795-9. PubMed ID: 15867493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histomorphometric and immunohistochemical analysis of infectious agents, T-cell subpopulations and inflammatory adhesion molecules in placentas from HIV-seropositive pregnant women.
    Baurakiades E; Martins AP; Victor Moreschi N; Souza CD; Abujamra K; Saito AO; Mecatti MC; Santos MG; Pimentel CR; Silva LL; Cruz CR; de Noronha L
    Diagn Pathol; 2011 Oct; 6():101. PubMed ID: 22024147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The distribution of immunocompetent cells in the genital tract of HIV-positive women.
    Olaitan A; Johnson MA; MacLean A; Poulter LW
    AIDS; 1996 Jun; 10(7):759-64. PubMed ID: 8805867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nevirapine-associated hepatotoxicity and rash among HIV-infected pregnant women in Kenya.
    Peters PJ; Polle N; Zeh C; Masaba R; Borkowf CB; Oyaro B; Omolo P; Ogindo P; Ndivo R; Angira F; Lando R; Fowler MG; Weidle PJ; Thomas TK
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(2):142-9. PubMed ID: 22020069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment.
    Kvale D; Ormaasen V; Kran AM; Johansson CC; Aukrust P; Aandahl EM; Frøland SS; Taskén K
    AIDS; 2006 Apr; 20(6):813-20. PubMed ID: 16549964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High rates of baseline antiretroviral resistance among HIV-infected pregnant women in an HIV referral centre in Rio de Janeiro, Brazil.
    de Lourdes Teixeira M; Nafea S; Yeganeh N; Santos E; Gouvea MI; Joao E; Ceci L; Bressan C; Cruz ML; Sidi LC; Nielsen-Saines K
    Int J STD AIDS; 2015 Nov; 26(13):922-8. PubMed ID: 25504831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Young women with HIV infection acquired by vertical transmission: Expectations of having uninfected children].
    Villarroel J; Álvarez AM; Salvador F; Chávez A; Wu E; Contardo V
    Rev Chilena Infectol; 2016 Dec; 33(6):650-655. PubMed ID: 28146189
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of pregnancy on survival in women infected with HIV: a systematic review of the literature and meta-analysis.
    French R; Brocklehurst P
    Br J Obstet Gynaecol; 1998 Aug; 105(8):827-35. PubMed ID: 9746374
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Serum vitamin A during pregnancy and effects on obstetrics and perinatal outcomes in HIV infected pregnant women].
    El Beitune P; Duarte G; Vannucchi H; Quintana SM; Figueiró-Filho EA; de Morais EN; Nogueira AA
    Arch Latinoam Nutr; 2004 Dec; 54(4):419-27. PubMed ID: 15969267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.